Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000096:biosynthesis*; D000942:Antigens, Bacterial / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology*; D002677:Chile; D005602:France; D006386:Hemagglutination Tests; D006801:Humans; D008396:Maryland; D019081:O Antigens; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012485:Salmonella typhi / Q000276:immunology*; D014435:Typhoid Fever / Q000453:epidemiology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D019081:O Antigens; D011135:Polysaccharides, Bacterial